The Effects of Medical Conditions on Driving Performance: A Literature Review and Synthesis
archive: archived pipeline: cataloged verified
Get this paper ↗ (full text — opens at the source; we link to it, we don't host it)
Summary
This report, published by the National Highway Traffic Safety Administration (NHTSA) in 2018, synthesizes existing literature on how medical conditions affect the driving performance and safety of older adults. The research was motivated by a lack of empirical data linking common age-related medical conditions to realistic driving outcomes, as prior understanding relied heavily on expert opinion or simulation studies. The authors aimed to integrate findings from two previous NHTSA projects to evaluate the prevalence of specific conditions, their impact on functional abilities required for driving, and their association with crash and violation risks. The methodology involved a comprehensive literature search of peer-reviewed journals, technical reports, and government documents published between 2000 and 2011. Researchers utilized databases such as TRID, MedLine, and PsycINFO, searching for studies that observed driver performance or analyzed crash data in relation to medical conditions. Studies relying solely on self-report data were excluded. The review focused on three domains of disorders: endocrine and metabolic (e.g., diabetes, hepatic encephalopathy), neurological and physical (e.g., dementia, stroke, Parkinson’s disease, obstructive sleep apnea), and visual/sensory (e.g., glaucoma, macular degeneration). The synthesis prioritized conditions with the highest potential for impaired performance and crash risk among older drivers. The findings detail how specific conditions impair the cognitive, visual, and psychomotor functions necessary for safe driving. For instance, the report highlights that diabetes affects driving through acute events like hypoglycemia, which causes transient cognitive dysfunction, and chronic complications like retinopathy and neuropathy. Simulator studies cited in the review indicate that while Type I diabetics may maintain driving performance comparable to non-diabetics under normal conditions, their performance degrades significantly during hypoglycemia, particularly for those with a history of driving mishaps. Type II diabetics showed poorer performance even under normal blood sugar levels. The report also notes that medications used to treat these conditions, such as anti-diabetic drugs, may contribute to crash risk independently of the disease itself. The significance of this synthesis lies in its identification of medical conditions that pose particular concerns for driving safety, providing a evidence-based foundation for medical fitness guidelines. By linking specific functional impairments to driving outcomes, the report helps clarify which conditions and medication regimens require closer scrutiny for older drivers. The authors conclude that while a diagnosis alone may not always predict safety outcomes, the combination of functional impairment, medication use, and specific medical histories significantly influences crash risk. This work supports the development of more nuanced policies regarding driver licensing and medical monitoring for older adults.
Key finding
Type 2 diabetic drivers demonstrated degraded performance under hypoglycemic conditions, and Type 1 drivers with a history of hypoglycemic driving mishaps showed significantly worse simulated driving performance under low blood glucose levels compared to those without such a history.
Methodology
review
Provenance
The full processing record for this entry. Every stage of this paper's journey through the pipeline is logged — what ran, with which tool and model, how many attempts it took, and when it last completed. Discovered via bulk_ingest_rosap on 2026-05-23 (6 acquisition events logged).
| Stage | Outcome | Tool | Model | Prompt | Attempts | Completed |
|---|---|---|---|---|---|---|
| discover | success | rosap | — | — | 2 | 2026-05-23 |
| archive | success | — | — | — | 1 | 2026-05-23 |
| extract | success | cached | — | — | 2 | 2026-06-10 |
| clean | success | — | — | — | 1 | 2026-06-01 |
| chunk | success | — | — | — | 1 | 2026-06-01 |
| embed | success | — | — | — | 1 | 2026-06-02 |
| enrich | success | — | — | — | 1 | 2026-05-23 |
| promote | success | — | — | — | 1 | 2026-05-23 |
| summarize | success | llm | qwen3.6-27b-prismaquant | summ-v5 | 3 | 2026-06-10 |
| tag | success | vector_similarity | — | — | 19 | 2026-06-11 |
| verify | partial | — | — | — | 2 | 2026-06-10 |
Summary generated by qwen3.6-27b-prismaquant on 2026-06-10; verification: verified_with_issues.
Topics
Ranked by relevance to this paper. Hover a topic for its definition.
- mci dementia driving
- medical conditions
- cognitive impairment
- prescription meds
- cognitive capacity variation
- sleep deprivation
Information type
What kind of knowledge this paper contributes, grouped by family — independent of topic (what it is about) and method (how it was studied).
- Empirical Findings: physiological data, behavioral performance data, observational prevalence